MENU
+Compare
CYYNF
Stock ticker: OTC
AS OF
Jan 6 closing price
Price
$0.14
Change
-$0.05 (-26.32%)
Capitalization
32.02M

CYYNF Cynata Therapeutics Ltd. Forecast, Technical & Fundamental Analysis

Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus... Show more

Ad is loading...
View a ticker or compare two or three
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
100 Cubitt Street
Phone
+61 370676940
Employees
2
Web
https://www.cynata.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IJH59.740.37
+0.62%
iShares Core S&P Mid-Cap ETF
USPX50.440.25
+0.49%
Franklin US Equity Index ETF
ESG138.250.59
+0.43%
FlexShares STOXX US ESG Select ETF
IWDL39.48N/A
N/A
ETRACS 2x Leveraged US Value Fctr TR ETN
GNMA43.60-0.08
-0.17%
iShares GNMA Bond ETF

CYYNF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CYYNF has been loosely correlated with CADL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CYYNF jumps, then CADL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYYNF
1D Price
Change %
CYYNF100%
N/A
CADL - CYYNF
46%
Loosely correlated
+5.22%
URGN - CYYNF
38%
Loosely correlated
-3.63%
MLLCF - CYYNF
31%
Poorly correlated
N/A
INKT - CYYNF
27%
Poorly correlated
+0.49%
BRTX - CYYNF
26%
Poorly correlated
+2.65%
More